Description

Phenibut FAA Powder

Phenibut FAA
CAS Number	1078-21-3
Molar Mass	179.22 g·mol−1
Chemical Formula	C10H13NO2
IUPAC Name	4-amino-3-phenylbutanoic acid

Introduction

Phenibut FAA (Free Amino Acid) Powder is a research compound known for its potential effects on cognition, human growth hormone, and sleep. It is crucial to emphasize that this product is strictly intended for research purposes, and any mention of human consumption is strictly prohibited.

Key Characteristics

Phenibut FAA is a modified version of phenibut, designed for enhanced bioavailability. As a GABA analogue, it interacts with the GABA receptors in the brain, influencing neurotransmission and potentially yielding various effects.

Research Applications

This compound’s applications in research are diverse, spanning neuroscience, endocrinology, and sleep studies. Researchers explore its impact on cognitive function, hormonal regulation, and sleep patterns.

Research Benefits

Phenibut FAA and Cognition

Studies suggest that Phenibut FAA may influence cognitive function, potentially affecting memory and learning processes. Researchers investigate its mechanisms of action and potential applications in cognitive research.

Phenibut FAA and Human Growth Hormone

Research indicates a possible link between Phenibut FAA and the regulation of human growth hormone (HGH). Studies explore the interactions between Phenibut FAA and the endocrine system, shedding light on its role in HGH release.

Phenibut FAA and Sleep

Phenibut FAA’s impact on sleep patterns is a subject of interest in sleep research. Preliminary studies suggest a potential role in promoting relaxation and influencing sleep architecture.

Summary

Phenibut FAA Powder holds promise as a research tool in various scientific domains. Its potential effects on cognition, human growth hormone, and sleep make it a valuable compound for investigators exploring neural, endocrine, and sleep-related phenomena.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Shul’gina GI, Ziablitseva EA. Vliianie proizvodnogo GAMK fenibuta na obuchenie [Effect of the GABA derivative phenibut on learning]. Vestn Ross Akad Med Nauk. 2005;(2):35-40. Russian. PMID: 15776965. [Read More].
2. Cavagnini F, Invitti C, Pinto M, Maraschini C, Di Landro A, Dubini A, Marelli A. Effect of acute and repeated administration of gamma aminobutyric acid (GABA) on growth hormone and prolactin secretion in man. Acta Endocrinol (Copenh). 1980 Feb;93(2):149-54. doi: 10.1530/acta.0.0930149. PMID: 7376786. [Read More].
3. Vorob’eva OV, Rusaya VV. Farmakoterapiya trevozhnykh rasstroistv u patsientov s khronicheskoi ishemiei golovnogo mozga [Pharmacotherapy of anxiety disorders in patients with chronic cerebral ischemia]. Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(12. Vyp. 2):49-55. Russian. doi: 10.17116/jnevro201611612249-54. PMID: 28300804. [Read More].